Overall, our findings support a contributing role for TG2 to the pathogenesis of experimental models for MS resulting in monocyte infiltration into the CNS, which is a key factor in the development of clinical symptoms (Lassmann 2011). Here, TGM2 is linked to myeloid sarcoma.